To better understand the metabolic changes in prostatic tumor development caused by altered vascular supply, cellular apoptosis and proliferation were addressed by immunostaining for active caspase 3 and ki67, respectively, on prostate samples from TRAMP.eJag1 mutants (Figure 7). The gene discussed is MKI67; the disease is prostate neoplasm.